Study Protocol
The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)
Zhonghan Zhang, Fan Luo, Yang Zhang, Yuxiang Ma, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang & Hongyun Zhao
[ [Abstract ] [ Abstract 185] [ PDF Full-text 169] [ PubMed] Epub: 11/7/2019 doi:10.1186/s40880-019-0414-4
Original article
Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification
Zhi-Xia Yue, Tian-Yu Xing, Chao Gao, Shu-Guang Liu, Wen Zhao, Qian Zhao, Xi-Si Wang, Mei Jin & Xiao-Li Ma
[ [Abstract ] [ Abstract 191] [ PDF Full-text 192] [ PubMed] Epub: 11/4/2019 doi:10.1186/s40880-019-0409-1
Letter to the Editor
A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment
Hideharu Kimura, Yoshiaki Amino, Hayato Koba, Yuichi Tambo, Noriyuki Ohkura, Johsuke Hara, Takashi Sone & Kazuo Kasahara
[ [Abstract ] [ Abstract 163] [ PDF Full-text 173] [ PubMed] Epub: 11/1/2019 doi:10.1186/s40880-019-0413-5
Original article
Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis
Wentao Zhou, Weiwei Jin, Dansong Wang, Chao Lu, Xuefeng Xu, Renchao Zhang, Tiantao Kuang, Yucheng Zhou, Wenchuan Wu, Dayong Jin, Yiping Mou & Wenhui Lou
[ [Abstract ] [ Abstract 194] [ PDF Full-text 183] [ PubMed] Epub: 10/28/2019 doi:10.1186/s40880-019-0410-8
Research highlight
S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer
Feiyu Diao, Wei Lai & Zhonghua Chu
[ [Abstract ] [ Abstract 205] [ PDF Full-text 161] [ PubMed] Epub: 10/26/2019 doi:10.1186/s40880-019-0408-2
Research highlight
Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma
Li-Ting Liu, Melvin L. K. Chua, Yungan Tao, Lin-Quan Tang & Hai-Qiang Mai
[ [Abstract ] [ Abstract 172] [ PDF Full-text 148] [ PubMed] Epub: 10/25/2019 doi:10.1186/s40880-019-0398-0
Research highlight
Targeting mitochondria as an anticancer strategy
Lanfeng Dong & Jiri Neuzil
[ [Abstract ] [ Abstract 123] [ PDF Full-text 132] [ PubMed] Epub: 10/25/2019 doi:10.1186/s40880-019-0412-6
Original article
Incidence trends and survival prediction of hepatoblastoma in children: a population-based study
Jincheng Feng, Georgios Polychronidis, Ulrike Heger, Giovanni Frongia, Arianeb Mehrabi & Katrin Hoffmann
[ [Abstract ] [ Abstract 114] [ PDF Full-text 115] [ PubMed] Epub: 10/24/2019 doi:10.1186/s40880-019-0411-7
Mini Review
New frontiers in proton therapy: applications in cancers
Tai-Ze Yuan, Ze-Jiang Zhan & Chao-Nan Qian
[ [Abstract ] [ Abstract 91] [ PDF Full-text 111] [ PubMed] Epub: 10/22/2019 doi:10.1186/s40880-019-0407-3
Original article
Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database
Gary D. Lewis, Yan Xing, Waqar Haque, Tejal Patel, Mary Schwartz, Albert Chen, Andrew Farach, Sandra S. Hatch, E. Brian Butler, Jenny Chang & Bin S. Teh
[ [Abstract ] [ Abstract 85] [ PDF Full-text 111] [ PubMed] Epub: 10/21/2019 doi:10.1186/s40880-019-0406-4
